Lubrizol shanghai innovation center reopens, accelerating innovation and collaboration in asia pacific

• Deepen Localized Innovation Layout and Build a New Highland for Asia-Pacific Synergy
• Brand new, medical grade Tolerathane™ Thermoplastic Polyurethane Heavyweight Release to Empower Next-Generation Implantable Medical Devices
• Carbopol^® Polymer pharmaceutical solutions, empowering the health industry.

Shanghai, China 2026 2 4 —— Lubrizol Corporation, a global leader in specialty chemicals, today announced the relaunch of the Lubrizol Shanghai Innovation Center at its Songjiang manufacturing facility in Shanghai. The center will serve as another innovation hub for Lubrizol in the Asia Pacific region, accelerating innovation, deepening customer collaboration, and promoting cross-industry co-creation.

From left: Lubrizol Asia Pacific Vice President Liu Maoshu, Lubrizol Global Vice President and Chief Financial Officer Davis Walker, Lubrizol President and CEO Rebecca LiebertWang Xingwang, Senior Technical Director, Lubrizol Asia Pacific

At the inauguration ceremony, Lubrizol also highlighted two innovations: innovative materials for implantable medical devices. Tolerathane™ Thermoplastic polyurethane (TPU) TPU), and those for pharmaceutical applicationsCarbopol^® Polymer innovation solutions. These new products and solutions will continue to drive technological breakthroughs and market development in high-growth areas such as healthcare.

Lubrizol APAC Vice President, Allen Liu, stated: “The relaunch of Lubrizol's Shanghai Innovation Center marks a significant milestone in the company's continuous efforts to strengthen regional innovation capabilities and accelerate localization, better meeting the diverse needs of the Asia Pacific market. The center not only empowers innovation with high-standard R&D facilities but will also serve as an open platform for cross-industry collaboration and breakthrough innovation. We look forward to combining Lubrizol's global technologies and experience with local insights and talent advantages, working hand-in-hand with our partners to continuously launch more sustainable solutions, enhance human well-being, and empower modern living.”

Lubrizol Shanghai Innovation Center, Solidifying the Foundation of Local Innovation

Lubrizol Shanghai Innovation Center combines advanced laboratory capabilities with Lubrizol's deep global technology accumulation, focusing on industries such as mobility and transportation, infrastructure, electronics, sports and fashion, beauty and personal care, and healthcare, to continuously create market-driven, high-value innovative solutions.

Leveraging Lubrizol's well-established innovation network in the Asia-Pacific region, including the Southeast Asia Innovation Center and the Footwear Application Development Center of Excellence, these innovation platforms collectively build a market-responsive innovation ecosystem, accelerate the localization of innovation, and help local innovations go global and achieve scaled growth.

New medical-grade materials empower the next generation of implantable medical devices.

Lubrizol has officially launched its new medical-grade thermoplastic polyurethane (TPU). TPUMaterials ——Tolerathane™ TPU. The material To satisfy 植入式医疗器械不断升级的 Developed to meet the needs, it achieves advancements in biostability, softness, and design flexibility. Significant breakthrough.

Tolerathane™ TPUExhibits excellent antioxidant and hydrolytic resistance in harsh biological environments, maintaining mechanical integrity and softness even at the lowest hardness. Its thermoplastic nature allows for seamless adaptation to common thermal processing techniques and enables performance optimization through formulation adjustments, offering greater design freedom for medical devices.

Tolerathane™ TPU支持更纤薄的壁厚和微型化结构设计，是替代植入级硅胶材料的理想热塑性方案。其性能优势高度契合多种植入式应用的技术要求， Includes a wide range of advanced medical devices such as neuromodulation leads, pacing leads and stimulation devices, structural heart devices, implantable and percutaneous catheters and cables, and implantable medical textiles.  

Innovative Solutions Empowering the Pharmaceutical Industry

Lubrizol also offers innovative solutions for the pharmaceutical industry based on mature bioadhesion technology. Carbopol^®  Polymer solutions. In ophthalmic, nasal, oral, and other mucosal delivery applications, conventional formulations often suffer from limitations such as short duration of action and low bioavailability. These issues can limit therapeutic efficacy, increase dosing frequency, and negatively impact patient compliance.

As a widely recognized, industry-leading bioadhesive material. Carbopol^®  Polymers can significantly extend drug action time, helping to improve the effectiveness and safety of local treatments. Leveraging its deep expertise in materials science and formulation design, Lubrizol provides high-performance materials and comprehensive technical support for drug delivery and formulation development, helping pharmaceutical companies address R&D challenges and accelerate the commercialization of innovative topical drug delivery systems.

Lubrizol Corporation

路博润公司是伯克希尔·Hathaway Company Berkshire HathawayA specialty chemical company within [Parent Company Name], Lubrizol is committed to delivering sustainable solutions that enable mobility, improve wellbeing and enhance modern life. Every day, Lubrizol’s innovators use science as their foundation and market insights as their guide to deliver exceptional value to customers. By driving discoveries and creating breakthrough solutions, we improve people’s lives and make the world a better place. Lubrizol was founded in [Year]. 1928year, with manufacturing facilities, sales and technical offices globally, and nearly employees. 7000People, with clients all over 100countries and territories.